-
Comparison of the effect of intravenous saline hydration on serum creatinine concentration between patients with or without iodine contrast administration
Rzezniczak Janusz, Synowiec Tomasz, Hiczkiewicz Jarosław, Slomczynski Marek, Dariusz Angerer, Palasz Anna, Jakub Zurawski, Burchardt Pawel
Research Article: Clinical Investigation
-
Comparison of the effect of intravenous saline hydration on serum creatinine concentration between patients with or without iodine contrast administration
Rzezniczak Janusz, Synowiec Tomasz, Hiczkiewicz Jarosław, Slomczynski Marek, Dariusz Angerer, Palasz Anna, Jakub Zurawski, Burchardt Pawel
Research Article: Clinical Investigation
-
Comparison of the effect of intravenous saline hydration on serum creatinine concentration between patients with or without iodine contrast administration
Rzezniczak Janusz, Synowiec Tomasz, Hiczkiewicz Jarosław, Slomczynski Marek, Dariusz Angerer, Palasz Anna, Jakub Zurawski, Burchardt Pawel
Research Article: Clinical Investigation
-
Comparison of the effect of intravenous saline hydration on serum creatinine concentration between patients with or without iodine contrast administration
Rzezniczak Janusz, Synowiec Tomasz, Hiczkiewicz Jarosław, Slomczynski Marek, Dariusz Angerer, Palasz Anna, Jakub Zurawski, Burchardt Pawel
Research Article: Clinical Investigation
-
Comparison of the effect of intravenous saline hydration on serum creatinine concentration between patients with or without iodine contrast administration
Rzezniczak Janusz, Synowiec Tomasz, Hiczkiewicz Jarosław, Slomczynski Marek, Dariusz Angerer, Palasz Anna, Jakub Zurawski, Burchardt Pawel
Research Article: Clinical Investigation
-
Comparison of the effect of intravenous saline hydration on serum creatinine concentration between patients with or without iodine contrast administration
Rzezniczak Janusz, Synowiec Tomasz, Hiczkiewicz Jarosław, Slomczynski Marek, Dariusz Angerer, Palasz Anna, Jakub Zurawski, Burchardt Pawel
Research Article: Clinical Investigation
-
Comparison of the effect of intravenous saline hydration on serum creatinine concentration between patients with or without iodine contrast administration
Rzezniczak Janusz, Synowiec Tomasz, Hiczkiewicz Jarosław, Slomczynski Marek, Dariusz Angerer, Palasz Anna, Jakub Zurawski, Burchardt Pawel
Research Article: Clinical Investigation
-
Comparison of the effect of intravenous saline hydration on serum creatinine concentration between patients with or without iodine contrast administration
Rzezniczak Janusz, Synowiec Tomasz, Hiczkiewicz Jarosław, Slomczynski Marek, Dariusz Angerer, Palasz Anna, Jakub Zurawski, Burchardt Pawel
Research Article: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Co-morbidities and their underappreciated impact on the conversion of oncology trial results into routine clinical practice
Maurie Markman
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation
-
The early clinical development of a multicomponent vaccine against meningococcal serogroup B
James Wassil
Review: Clinical Trail Outcomes: Clinical Investigation